Coffee review

Drinking coffee regularly can reduce the risk of basal cell cancer.

Published: 2024-11-05 Author: World Gafei
Last Updated: 2024/11/05, Washington, July 6 (Reporter Ren Haijun) A study completed by researchers at Harvard Medical School a few days ago shows that drinking caffeinated coffee often helps to reduce the risk of common skin cancer, basal cell cancer. The researchers analyzed the data of 112000 people who participated in the Health Occupational follow-up study and Nurse Health study for more than 20 years and found that they drank more than 3 cups of coffee a day.

WASHINGTON, July 6 (Xinhua Ren Navy) Harvard Medical School researchers recently completed research shows that drinking caffeinated coffee often helps reduce the risk of common skin cancer-basal cell carcinoma.

The researchers analyzed data from 112,000 participants in the Health Career Follow-up Study and the Nurses 'Health Study over 20 years and found that women who drank more than three cups of caffeinated coffee a day had a 21 percent lower risk of basal cell cancer than those who drank less than one cup a month; for similar men, the risk was reduced by 10 percent.

They also found that regular consumption of caffeinated tea or chocolate had the same effect, but did not reduce the risk of squamous cell carcinoma, melanoma and other skin cancers; drinking caffeine-free coffee was not associated with the risk of basal cell carcinoma.

The study was published this week in the American journal Cancer Research. Previous studies in mice have shown caffeine can inhibit tumor growth, and this study suggests caffeine may have a similar effect in humans, the researchers said.

Basal cell carcinoma (BCC) is the most common skin malignancy, often affecting the face. In foreign countries, more than half of skin cancer patients suffer from basal cell carcinoma. According to the National Cancer Institute, about one million people in the United States receive treatment for basal cell carcinoma each year.

0